Neuralink received FDA approval for human clinical trials. Synchron already had humans with implanted brain-computer interfaces. BrainGate has been publishing peer-reviewed human trial results for years. The technology is not theoretical. It is implanted in human skulls right now, reading neural signals, and in some applications, writing them back.
The stated applications are genuinely extraordinary in the compassion they represent: restoring communication for people with ALS, enabling paralyzed individuals to control devices through thought, potentially addressing treatment-resistant depression through closed-loop neural stimulation. These are real benefits. These are lives meaningfully improved.
And they are also, simultaneously, the commercialization pathway for a technology whose eventual applications extend far beyond the clinic and into territory that nobody who isn't being paid to be optimistic about it is entirely comfortable with.
The question that neither the FDA approval process, nor the Neuralink marketing, nor the breathless tech press coverage has seriously engaged is: what does a mass-market brain-computer interface mean for human autonomy?
Not in the distant sci-fi future. In the same commercial timeline as the smartphone, which went from niche enterprise tool to universal behavioral modification device in about fifteen years.
A neural interface that reads your brain state in real time generates a category of data that has never existed before: not your behavior, not your words, not your purchases, but the actual electrical activity of your cognition. Your attention, your emotional responses, your decision-making processes — available as a data stream to whatever company operates the hardware.
Neuralink's privacy policy covers this. It covers it in terms of service language written by attorneys for attorneys.
The history of every transformative consumer technology is that the commercial incentives of the platforms that deploy it outpace the regulatory frameworks designed to govern it. Usually by a decade. Usually at the consumer's expense.
The race to put chips in human heads is not waiting for a philosophical consensus on what it means. It has venture capital. It has FDA clearance. It has a waitlist.
You weren't asked if you wanted the race to start.
SOURCE LINK: https://www.fda.gov/news-events/press-announcements/fda-breakthrough-device-designation-neuralink
Comments
Post a Comment